Home > Publications database > Circulating free testosterone and risk of aggressive prostate cancer: prospective and Mendelian randomization analyses in international consortia. > print

001     179958
005     20240229145600.0
024 7 _ |a 10.1002/ijc.34116
|2 doi
024 7 _ |a pmid:35579976
|2 pmid
024 7 _ |a 0020-7136
|2 ISSN
024 7 _ |a 1097-0215
|2 ISSN
024 7 _ |a altmetric:128456247
|2 altmetric
037 _ _ |a DKFZ-2022-01007
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Watts, Eleanor L
|0 0000-0001-9229-2589
|b 0
245 _ _ |a Circulating free testosterone and risk of aggressive prostate cancer: prospective and Mendelian randomization analyses in international consortia.
260 _ _ |a Bognor Regis
|c 2022
|b Wiley-Liss
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1660553602_9214
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a 2022 Oct 1;151(7):1033-1046
520 _ _ |a Previous studies had limited power to assess the associations of testosterone with aggressive disease as a primary endpoint. Further, the association of genetically predicted testosterone with aggressive disease is not known. We investigated the associations of calculated free and measured total testosterone and sex hormone-binding globulin (SHBG) with aggressive, overall and early-onset prostate cancer. In blood-based analyses, odds ratios (OR) and 95% confidence intervals (CI) for prostate cancer were estimated using conditional logistic regression from prospective analysis of biomarker concentrations in the Endogenous Hormones, Nutritional Biomarkers and Prostate Cancer Collaborative Group (up to 25 studies, 14,944 cases and 36,752 controls, including 1,870 aggressive prostate cancers). In Mendelian randomization (MR) analyses, using instruments identified using UK Biobank (up to 194,453 men) and outcome data from PRACTICAL (up to 79,148 cases and 61,106 controls, including 15,167 aggressive cancers), ORs were estimated using the inverse-variance weighted method. Free testosterone was associated with aggressive disease in MR analyses (OR per 1 SD=1.23, 95% CI=1.08-1.40). In blood-based analyses there was no association with aggressive disease overall, but there was heterogeneity by age at blood collection (OR for men aged <60 years 1.14, CI=1.02-1.28; Phet =0.0003: inverse association for older ages). Associations for free testosterone were positive for overall prostate cancer (MR:1.20,1.08-1.34; blood-based:1.03,1.01-1.05) and early-onset prostate cancer (MR:1.37,1.09-1.73; blood-based:1.08,0.98-1.19). SHBG and total testosterone were inversely associated with overall prostate cancer in blood-based analyses, with null associations in MR analysis. Our results support free testosterone, rather than total testosterone, in the development of prostate cancer, including aggressive subgroups.
536 _ _ |a 313 - Krebsrisikofaktoren und Prävention (POF4-313)
|0 G:(DE-HGF)POF4-313
|c POF4-313
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
700 1 _ |a Perez-Cornago, Aurora
|0 0000-0002-5652-356X
|b 1
700 1 _ |a Fensom, Georgina K
|b 2
700 1 _ |a Smith-Byrne, Karl
|b 3
700 1 _ |a Noor, Urwah
|b 4
700 1 _ |a Andrews, Colm D
|b 5
700 1 _ |a Gunter, Marc J
|b 6
700 1 _ |a Holmes, Michael V
|b 7
700 1 _ |a Martin, Richard M
|b 8
700 1 _ |a Tsilidis, Konstantinos K
|0 0000-0002-8452-8472
|b 9
700 1 _ |a Albanes, Demetrius
|b 10
700 1 _ |a Barricarte, Aurelio
|b 11
700 1 _ |a Bueno-de-Mesquita, H Bas
|b 12
700 1 _ |a Chen, Chu
|b 13
700 1 _ |a Cohn, Barbara A
|b 14
700 1 _ |a Dimou, Niki L
|0 0000-0003-1678-9328
|b 15
700 1 _ |a Ferrucci, Luigi
|b 16
700 1 _ |a Flicker, Leon
|b 17
700 1 _ |a Freedman, Neal D
|b 18
700 1 _ |a Giles, Graham G
|b 19
700 1 _ |a Giovannucci, Edward L
|b 20
700 1 _ |a Goodman, Gary E
|b 21
700 1 _ |a Haiman, Christopher A
|b 22
700 1 _ |a Hankey, Graeme J
|b 23
700 1 _ |a Huang, Jiaqi
|0 0000-0002-7808-9477
|b 24
700 1 _ |a Huang, Wen-Yi
|b 25
700 1 _ |a Hurwitz, Lauren M
|0 0000-0001-8932-5028
|b 26
700 1 _ |a Kaaks, Rudolf
|0 P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a
|b 27
|u dkfz
700 1 _ |a Knekt, Paul
|b 28
700 1 _ |a Kubo, Tatsuhiko
|b 29
700 1 _ |a Langseth, Hilde
|b 30
700 1 _ |a Laughlin, Gail
|b 31
700 1 _ |a Le Marchand, Loic
|b 32
700 1 _ |a Luostarinen, Tapio
|0 0000-0003-3231-8550
|b 33
700 1 _ |a MacInnis, Robert J
|b 34
700 1 _ |a Mäenpää, Hanna O
|b 35
700 1 _ |a Männistö, Satu
|b 36
700 1 _ |a Metter, E Jeffrey
|b 37
700 1 _ |a Mikami, Kazuya
|b 38
700 1 _ |a Mucci, Lorelei A
|b 39
700 1 _ |a Olsen, Anja W
|b 40
700 1 _ |a Ozasa, Kotaro
|b 41
700 1 _ |a Palli, Domenico
|0 0000-0002-5558-2437
|b 42
700 1 _ |a Penney, Kathryn L
|b 43
700 1 _ |a Platz, Elizabeth A
|0 0000-0003-3676-8954
|b 44
700 1 _ |a Rissanen, Harri
|b 45
700 1 _ |a Sawada, Norie
|0 0000-0002-9936-1476
|b 46
700 1 _ |a Schenk, Jeannette M
|b 47
700 1 _ |a Stattin, Pär
|b 48
700 1 _ |a Tamakoshi, Akiko
|b 49
700 1 _ |a Thysell, Elin
|b 50
700 1 _ |a Tsai, Chiaojung Jillian
|b 51
700 1 _ |a Tsugane, Shoichiro
|b 52
700 1 _ |a Vatten, Lars
|b 53
700 1 _ |a Weiderpass, Elisabete
|0 0000-0003-2237-0128
|b 54
700 1 _ |a Weinstein, Stephanie J
|b 55
700 1 _ |a Wilkens, Lynne R
|b 56
700 1 _ |a Yeap, Bu B
|b 57
700 1 _ |a PRACTICAL consortium, CRUK, BPC, CAPS, PEGASUS
|b 58
|e Collaboration Author
700 1 _ |a Allen, Naomi E
|b 59
700 1 _ |a Key, Timothy J
|b 60
700 1 _ |a Travis, Ruth C
|b 61
700 1 _ |a Eeles, Rosalind A
|b 62
700 1 _ |a Haiman, Christopher A
|b 63
700 1 _ |a Kote-Jarai, Zsofia
|b 64
700 1 _ |a Schumacher, Fredrick R
|b 65
700 1 _ |a Benlloch, Sara
|b 66
700 1 _ |a Olama, Ali Amin Al
|b 67
700 1 _ |a Muir, Kenneth R
|b 68
700 1 _ |a Berndt, Sonja I
|b 69
700 1 _ |a Conti, David V
|b 70
700 1 _ |a Wiklund, Fredrik
|b 71
700 1 _ |a Chanock, Stephen
|b 72
700 1 _ |a Wang, Ying
|b 73
700 1 _ |a Tangen, Catherine M
|b 74
700 1 _ |a Batra, Jyotsna
|b 75
700 1 _ |a Clements, Judith A
|b 76
700 1 _ |a BioResource, Apcb
|b 77
700 1 _ |a Grönberg, Henrik
|b 78
700 1 _ |a Pashayan, Nora
|b 79
700 1 _ |a Schleutker, Johanna
|b 80
700 1 _ |a Albanes, Demetrius
|b 81
700 1 _ |a Weinstein, Stephanie
|b 82
700 1 _ |a Wolk, Alicja
|b 83
700 1 _ |a West, Catharine M L
|b 84
700 1 _ |a Mucci, Lorelei A
|b 85
700 1 _ |a Cancel-Tassin, Géraldine
|b 86
700 1 _ |a Koutros, Stella
|b 87
700 1 _ |a Sørensen, Karina Dalsgaard
|b 88
700 1 _ |a Grindedal, Eli Marie
|b 89
700 1 _ |a Neal, David E
|b 90
700 1 _ |a Hamdy, Freddie C
|b 91
700 1 _ |a Donovan, Jenny L
|b 92
700 1 _ |a Travis, Ruth C
|b 93
700 1 _ |a Hamilton, Robert J
|b 94
700 1 _ |a Ingles, Sue Ann
|b 95
700 1 _ |a Rosenstein, Barry S
|b 96
700 1 _ |a Lu, Yong-Jie
|b 97
700 1 _ |a Giles, Graham G
|b 98
700 1 _ |a MacInnis, Robert J
|b 99
700 1 _ |a Kibel, Adam S
|b 100
700 1 _ |a Vega, Ana
|b 101
700 1 _ |a Kogevinas, Manolis
|b 102
700 1 _ |a Penney, Kathryn L
|b 103
700 1 _ |a Park, Jong Y
|b 104
700 1 _ |a Stanford, Janet L
|b 105
700 1 _ |a Cybulski, Cezary
|b 106
700 1 _ |a Nordestgaard, Børge G
|b 107
700 1 _ |a Nielsen, Sune F
|b 108
700 1 _ |a Brenner, Hermann
|0 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
|b 109
|u dkfz
700 1 _ |a Maier, Christiane
|b 110
700 1 _ |a Kim, Jeri
|b 111
700 1 _ |a John, Esther M
|b 112
700 1 _ |a Teixeira, Manuel R
|b 113
700 1 _ |a Neuhausen, Susan L
|b 114
700 1 _ |a De Ruyck, Kim
|b 115
700 1 _ |a Razack, Azad
|b 116
700 1 _ |a Newcomb, Lisa F
|b 117
700 1 _ |a Lessel, Davor
|b 118
700 1 _ |a Kaneva, Radka
|b 119
700 1 _ |a Usmani, Nawaid
|b 120
700 1 _ |a Claessens, Frank
|b 121
700 1 _ |a Townsend, Paul A
|b 122
700 1 _ |a Castelao, Jose Esteban
|b 123
700 1 _ |a Roobol, Monique J
|b 124
700 1 _ |a Menegaux, Florence
|b 125
700 1 _ |a Khaw, Kay-Tee
|b 126
700 1 _ |a Cannon-Albright, Lisa
|b 127
700 1 _ |a Pandha, Hardev
|b 128
700 1 _ |a Thibodeau, Stephen N
|b 129
700 1 _ |a Hunter, David J
|b 130
700 1 _ |a Kraft, Peter
|b 131
700 1 _ |a Blot, William J
|b 132
700 1 _ |a Riboli, Elio
|b 133
773 _ _ |a 10.1002/ijc.34116
|g p. ijc.34116
|0 PERI:(DE-600)1474822-8
|n 7
|p 1033-1046
|t International journal of cancer
|v 151
|y 2022
|x 0020-7136
909 C O |p VDB
|o oai:inrepo02.dkfz.de:179958
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 27
|6 P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 109
|6 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-313
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Krebsrisikofaktoren und Prävention
|x 0
914 1 _ |y 2022
915 _ _ |a DEAL Wiley
|0 StatID:(DE-HGF)3001
|2 StatID
|d 2021-02-04
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-02-04
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2021-02-04
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-02-04
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2022-11-25
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2022-11-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2022-11-25
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b INT J CANCER : 2021
|d 2022-11-25
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b INT J CANCER : 2021
|d 2022-11-25
920 1 _ |0 I:(DE-He78)C020-20160331
|k C020
|l C020 Epidemiologie von Krebs
|x 0
920 1 _ |0 I:(DE-He78)C070-20160331
|k C070
|l C070 Klinische Epidemiologie und Alternf.
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C020-20160331
980 _ _ |a I:(DE-He78)C070-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21